(Q74236230)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9480399%20AND%20SRC:MED&resulttype=core&format=json

reason for deprecated rank

9 November 2019

title

Penetrierendes Ulcus duodeni als Komplikation eines Arteria-hepatica-Portkatheters bei hepatisch metastasiertem Sigmakarzinom (German)

marking inconsistent with the registered/official identifier/name

1 reference

reason for deprecated rank

9 December 2024

Penetrating duodenal ulcer as a complication of a hepatic artery port catheter in hepatic metastasis of sigmoid carcinoma (English)

marking inconsistent with the registered/official identifier/name

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9480399

9 December 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9480399

9 December 2024

author name string

D. Jäger

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9480399

9 December 2024

J. Warzelhan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9480399

9 December 2024

E. Jäger

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9480399

9 December 2024

A. Knuth

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9480399

9 December 2024

language of work or name

German

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9480399

9 December 2024

publication date

1 November 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9480399%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

15 November 1997

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9480399

full work available at URL

9 December 2024

http://link.springer.com/content/pdf/10.1007/BF03044825.pdf

1 reference

http://link.springer.com/article/10.1007/BF03044825/fulltext.html

9 December 2024

file format

HyperText Markup Language

1 reference

http://link.springer.com/content/pdf/10.1007/BF03044825

9 December 2024

1 reference

9 December 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9480399%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

92

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9480399%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9480399%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

680-682

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9480399%20AND%20SRC:MED&resulttype=core&format=json

Phase II study of hepatic arterial floxuridine, leucovorin, and dexamethasone for unresectable liver metastases from colorectal carcinoma

9 November 2019

cites work

1 reference

12 December 2020

Percutaneous hepatic arterial infusion (HAI) of mitomycin C and floxuridine (FUDR): an effective treatment for metastatic colorectal carcinoma in the liver

1 reference

12 December 2020

Hepatic arterial floxuridine and leucovorin for unresectable liver metastases from colorectal carcinoma. New dose schedules and survival update

1 reference

12 December 2020

Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial

1 reference

12 December 2020

Gastroduodenal complications of hepatic intra-arterial chemotherapy of hepatic metastases of colorectal origin

1 reference

12 December 2020

Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases

1 reference

12 December 2020

Regional chemotherapy for hepatic metastases of colorectal carcinoma (continuous intraarterial versus continuous intraarterial/intravenous therapy). Results of a controlled clinical trial

1 reference

12 December 2020

Upper G-I bleeding following intraarterial chemotherapy infusion

1 reference

12 December 2020

Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial

1 reference

12 December 2020

Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial

1 reference

12 December 2020

CHEMOTHERAPY OF METASTATIC LIVER CANCER BY PROLONGED HEPATIC-ARTERY INFUSION

1 reference

12 December 2020

A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial

1 reference

12 December 2020

A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03044825

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9480399%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference